Changing trends in blood transfusion: An analysis of 244,013 hospitalizations

Transfusion

Volumn 54, Issue 1, 2014, Pages 2631-2639

  Shehata, Nadine ^a,b,c   Forster, Alan ^d,e   Lawrence, Nadine ^d   Rothwell, Deanna M ^d   Fergusson, Dean ^d   Tinmouth, Alan ^d,e   Wilson, Kumanan ^d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD CONSERVATION; BLOOD TRANSFUSION; DATA BASE; ERYTHROCYTE TRANSFUSION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; PLASMA TRANSFUSION; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; TREND STUDY; UNIVERSITY HOSPITAL; ADULT; CLINICAL TRIAL; FACTUAL DATABASE; HOSPITAL SUBDIVISIONS AND COMPONENTS; MULTICENTER STUDY; PLASMA; STATISTICS AND NUMERICAL DATA; TRANSFUSION MEDICINE; TRENDS; UTILIZATION;

ADULT; DATABASES, FACTUAL; ERYTHROCYTE TRANSFUSION; HOSPITAL UNITS; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; PLASMA; PLATELET TRANSFUSION; TRANSFUSION MEDICINE;

EID: 84908483786     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12644     Document Type: Article

References (29)

1. Chiavetta JA, Herst R, Freedman J, et al. A survey of red cell use in 45 hospitals in central Ontario, Canada. Transfusion 1996; 36: 699-706.
2. Wells AW, Mounter PJ, Chapman CE, et al. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002; 325 (7368): 803.
3. Cobain TJ, Vamvakas EC, Wells A, et al. A survey of the demographics of blood use. Transfus Med 2007; 17: 1-15.
4. Stanworth SJ, Cockburn HA, Boralessa H, et al. Which groups of patients are transfused? A study of red cell usage in London and southeast England. Vox Sang 2002; 83: 352-357.
5. Stanworth SJ, Walsh TS, Prescott RJ, et al.; Intensive Care Study of Coagulopathy (ISOC) investigators. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15: R108.
6. Walsh TS, Garrioch M, Maciver C, et al.; Audit of Transfusion in Intensive Care in Scotland Study Group. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 2004; 44: 1405-1411.
7. Chatterjee S, Wetterslev J, Sharma A, et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. Arch Intern Med 2013; 173: 132-139.
8. Carson JL, Hébert PC,. Here we go again-blood transfusion kills patients? Comment on "Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis." JAMA Intern Med 2013; 173: 139-141.
9. Yang L, Stanworth S, Hopewell S, et al. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012; 52: 1673-1686; quiz 1673.
10. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
11. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417.
12. Hébert PC, Blajchman MA, Cook DJ, et al.; Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group. Do blood transfusions improve outcomes related to mechanical ventilation? Chest 2001; 119: 1850-1857.
13. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507.
14. Williamson LM, Devine DV,. Challenges in the management of the blood supply. Lancet 2013; 381 (9880): 1866-1875.
15. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-2268.
16. Kulnigg S, Gasche C,. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006; 24 (11-12): 1507-1523.
17. Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008; 51: 103-112.
18. Silverberg DS, Iaina A, Schwartz D, et al. Intravenous iron in heart failure: beyond targeting anemia. Curr Heart Fail Rep 2011; 8: 14-21.
19. Auerbach M, Goodnough LT, Picard D, et al. The role of intravenous iron in anemia management and transfusion avoidance. Transfusion 2008; 48: 988-1000.
20. Wallis JP, Wells AW, Chapman CE,. Changing indications for red cell transfusion from 2000 to 2004 in the North of England. Transfus Med 2006; 16: 411-417.
21. Tay J, Tinmouth A, Fergusson D, et al. Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial. Trials 2011; 12: 207.
22. Stanworth SJ, Estcourt LJ, Powter G, et al.; TOPPS Investigators. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013; 368: 1771-1780.
23. Estcourt L, Stanworth S, Doree C, et al. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012;(5): CD004269.
24. Wandt H, Schaefer-Eckart K, Wendelin K, et al.; Study Alliance Leukemia. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012; 380 (9850): 1309-1316.
25. Zaffar N, Joseph A, Mazer CD, et al. The rationale for platelet transfusion during cardiopulmonary bypass: an observational study. Can J Anaesth 2013; 60: 345-354.
26. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004; 44: 1143-1148.
27. Karkouti K, Wijeysundera DN, Yau TM, et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth 2006; 53: 279-287.
28. Drackley A, Newbold KB, Paez A, et al. Forecasting Ontario's blood supply and demand. Transfusion 2012; 52: 366-374.
29. Greinacher A, Fendrich K, Brzenska R, et al. Implications of demographics on future blood supply: a population-based cross-sectional study. Transfusion 2011; 51: 702-709.